WDR1 Activators are a class of chemical compounds that can directly or indirectly enhance the functional activity of the WD repeat-containing protein 1 (WDR1), a protein known to be involved in the dynamics of actin cytoskeleton remodeling. This class of activators includes molecules that influence various biochemical pathways that converge on the actin cytoskeleton, an essential component of cellular structure and motility. WDR1 plays a role in the depolymerization of actin filaments, and thus, compounds that alter the balance of actin polymerization and depolymerization can influence WDR1 activity. For instance, agents that stabilize actin filaments or increase the concentration of actin monomers can enhance the activity of WDR1 by providing more substrate for its action or by changing the equilibrium of the actin dynamics in favor of the processes that WDR1 regulates.
Moreover, the chemical class termed WDR1 Activators encompasses a group of compounds that influence the activity of WDR1, a key player in the regulation of the actin cytoskeleton. These activators operate through various pathways that impact the dynamics of actin, either by stabilizing actin filaments, modulating actin monomer pools, or affecting the activity of proteins that interact with the actin cytoskeleton. For example, compounds like Jasplakinolide, by stabilizing actin filaments, create a cellular state that requires active reorganization of the cytoskeleton, thereby potentially enhancing the function of WDR1 in actin remodeling. Others, such as Cytochalasin D, act by binding to the barbed ends of actin filaments, preventing further polymerization and promoting depolymerization, which can result in an increased availability of actin monomers. This shift in the actin dynamics landscape is an environment where WDR1's role in actin filament turnover becomes critical, and thus its activity is enhanced.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels in cells. Elevated cAMP can enhance protein kinase A (PKA) activity, which can phosphorylate various substrates that may interact with or regulate WDR1, leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is known to phosphorylate a wide range of target proteins. PKC-mediated phosphorylation can lead to changes in the actin cytoskeleton, thereby potentially enhancing the activity of WDR1, which is involved in actin dynamics. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Calcium plays a critical role in the regulation of actin dynamics, and by extension, can enhance the activity of WDR1 in the reorganization of actin filaments. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 can lead to the stabilization and activation of various proteins that interact with the actin cytoskeleton, thus possibly enhancing WDR1 activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine stimulates adrenergic receptors, which can lead to the activation of cAMP-dependent pathways, similarly to forskolin, thereby potentially enhancing the activity of WDR1 through PKA signaling. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of cellular proteins. This inhibition can indirectly enhance the phosphorylation state of proteins that regulate actin dynamics, potentially enhancing WDR1 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases, which causes an increase in the phosphorylation of many proteins that could affect actin dynamics and thereby enhance the activity of WDR1. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can lead to the accumulation of filamentous actin (F-actin). This stabilization can affect WDR1 activity by influencing the dynamics of actin remodeling. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D binds to the barbed ends of actin filaments, preventing elongation and enhancing depolymerization. This can lead to an increase in the pool of actin monomers, potentially enhancing the activity of WDR1 in actin dynamics. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 inhibits myosin light chain kinase (MLCK), which can alter actin and myosin interaction dynamics. This alteration may indirectly enhance the activity of WDR1 by modulating actin filament turnover. | ||||||